Deal facts
- Buyer
- company owned by Luis Collantes
- Target
- Creo Medical SL
- Deal value
- Not disclosed
- Announced
- 22 May 2026
- Status
- Possible offer
- Sector
- Healthcare
- Country
- Spain
- Consideration
- cash
Sources
A company owned by Luis Collantes has agreed to acquire a minority stake in Creo Medical SL, a healthcare business based in Spain. The transaction involves cash consideration, though the specific financial value remains undisclosed. This deal was announced on 22 May 2026 and is currently classified as a possible offer. The target operates within the healthcare sector, while the buyer's country of origin is not reported in available records.
The acquisition represents a strategic entry into the Spanish healthcare market through a minority investment rather than a full takeover. As the deal is still in the early stages, it remains subject to further developments before any final agreement is reached. The transaction is subject to regulatory approval and further due diligence before completion.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- Possible offer
Proposed Sale of 49% Interest in Creo Medical SL
Disclaimer* THIS ANNOUNCEMENT WAS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 AS THEY FORM PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. WITH THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. Creo Medical Group plc ("Cr
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
YA II PN, LTD to acquire JUPITER NEUROSCIENCES, INC.
YA II PN, LTD and JUPITER NEUROSCIENCES, INC. entered the Exit Mode archive.
- Buyer
- YA II PN, LTD
- Target
- JUPITER NEUROSCIENCES, INC.
- Deal value
- USD 1,860,000
- Deal type
- minority stake
GSK plc to acquire Nuvalent, Inc
GSK plc has agreed to acquire Nuvalent, Inc in a strategic acquisition valued at $10.6 billion. The transaction, announced and completed on 15 July 2026, involves full c…
- Buyer
- GSK plc
- Target
- Nuvalent, Inc
- Deal value
- USD 10,600,000,000
- Deal type
- strategic acquisition
Volex plc to acquire Kepler SignalTek Ltd
Volex plc has agreed to acquire Kepler SignalTek Ltd, a healthcare sector business based in the United Kingdom. The strategic acquisition was announced and completed on…
- Buyer
- Volex plc
- Target
- Kepler SignalTek Ltd
- Deal value
- USD 89,400,000
- Deal type
- strategic acquisition
Trafalgar Asset Management, LLC to acquire The Greater Cannabis Company, Inc.
Trafalgar Asset Management, LLC has agreed to acquire The Greater Cannabis Company, Inc. in a going private transaction. The deal was announced on 6 July 2026, following…
- Buyer
- Trafalgar Asset Management, LLC
- Target
- The Greater Cannabis Company, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
COMREF Chiron IRF, LLC to acquire Chiron Real Estate Inc.
COMREF Chiron IRF, LLC has agreed to acquire Chiron Real Estate Inc. in an asset sale valued at USD 217 million. The transaction, which involves cash consideration only,…
- Buyer
- COMREF Chiron IRF, LLC
- Target
- Chiron Real Estate Inc.
- Deal value
- USD 217,000,000
- Deal type
- asset sale
Buyer history
company owned by Luis Collantes
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive